(Q43719531)

English

Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABA(B) receptor antagonists

scientific article published in September 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABA(B) receptor antagonists (English)

1 reference

Europe PubMed Central

26 November 2017

author name string

Pittaluga A

1

1 reference

Europe PubMed Central

26 November 2017

Feligioni M

2

1 reference

Europe PubMed Central

26 November 2017

Ghersi C

3

1 reference

Europe PubMed Central

26 November 2017

Gemignani A

4

1 reference

Europe PubMed Central

26 November 2017

Raiteri M

5

1 reference

Europe PubMed Central

26 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2001

1 reference

Europe PubMed Central

26 November 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Neuropharmacology

1 reference

Europe PubMed Central

26 November 2017

41

1 reference

Europe PubMed Central

26 November 2017

3

1 reference

Europe PubMed Central

26 November 2017

301-310

1 reference

Europe PubMed Central

26 November 2017

Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Molecular biology of somatostatin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

A synaptic model of memory: long-term potentiation in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Multiple GABAB receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Selective block of rat and human neocortex GABA(B) receptors regulating somatostatin release by a GABA(B) antagonist endowed with cognition enhancing activity

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortex

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Human brain somatostatin release from isolated cortical nerve endings and its modulation through GABAB receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

A presynaptic N-methyl-D-aspartate autoreceptor in rat hippocampus modulating amino acid release from a cytoplasmic pool

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

1-BCP, a memory-enhancing agent, selectively potentiates AMPA-induced [3H]norepinephrine release in rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Selective somatostatin sst(2) receptor blockade with the novel cyclic octapeptide, CYN-154806.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Presynaptic NMDA receptors stimulate noradrenaline release in the cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Cysteamine-induced depletion of central somatostatin-like immunoactivity: effects on behavior, learning, memory and brain neurochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Molecular pharmacology of somatostatin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

In vivo release of somatostatin from rat hippocampus and striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

FK960, a novel potential anti-dementia drug, augments long-term potentiation in mossy fiber-CA3 pathway of guinea-pig hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Changes in brain somatostatin in memory-deficient rats: comparison with cholinergic markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

CGP 36742: the first orally active GABAB blocker improves the cognitive performance of mice, rats, and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Selective depletion of somatostatin in rat brain by cysteamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Evidence for functional native NMDA receptors activated by glycine or D-serine alone in the absence of glutamatergic coagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Somatostatin potentiates NMDA receptor function via activation of InsP(3) receptors and PKC leading to removal of the Mg(2+) block without depolarization

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Synaptosomes still viable after 25 years of superfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

A simple apparatus for studying the release of neurotransmitters from synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Brain somatostatin: Receptor-coupled transducing mechanisms and role in cognitive functions

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Characterisation of human recombinant somatostatin receptors. 2. Modulation of GTPgammaS binding

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Characterisation of human recombinant somatostatin receptors. 4. Modulation of phospholipase C activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Facilitation of glutamate receptors enhances memory

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Characterization of human recombinant somatostatin sst5 receptors mediating activation of phosphoinositide metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Identifiers

10.1016/S0028-3908(01)00066-1

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43719531&oldid=2102816133"